Immunosuppressants - Monoclonal and Polyclonal Antibodies

Monoclonal and polyclonal antibody immunosuppressants are biologic agents engineered to modulate or inhibit targeted components of the host immune system In contrast, monoclonal antibodies selectively bind a single epitope to neutralize inflammatory cytokines or disrupt specific cell-surface receptors, such as interleukin-2 receptor antagonists or B-cell surface markers

Monoclonal and polyclonal antibody immunosuppressants are biologic agents engineered to modulate or inhibit targeted components of the host immune system Clinically, these agents are primarily indicated for the induction and treatment of solid-organ transplant rejection, prophylaxis of graft-versus-host disease, and the management of severe autoimmune and systemic inflammatory disorders

Polyclonal preparations, such as antithymocyte globulins, contain a heterogeneous mix of immunoglobulins that deplete circulating lymphocytes across diverse surface antigens Clinically, these agents are primarily indicated for the induction and treatment of solid-organ transplant rejection, prophylaxis of graft-versus-host disease, and the management of severe autoimmune and systemic inflammatory disorders

Polyclonal preparations, such as antithymocyte globulins, contain a heterogeneous mix of immunoglobulins that deplete circulating lymphocytes across diverse surface antigens In contrast, monoclonal antibodies selectively bind a single epitope to neutralize inflammatory cytokines or disrupt specific cell-surface receptors, such as interleukin-2 receptor antagonists or B-cell surface markers Clinically, these agents are primarily indicated for the induction and treatment of solid-organ transplant ...

In contrast, monoclonal antibodies selectively bind a single epitope to neutralize inflammatory cytokines or disrupt specific cell-surface receptors, such as interleukin-2 receptor antagonists or B-cell surface markers